A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy

BACKGROUND: The ideal prostate-specific antigen (PSA) doubling time (PSADT) threshold for identifying patients at high-risk for poor clinical outcome following salvage radiation therapy (SRT) has not been well established. We sought to assess what PSADT threshold is most clinically prognostic in thi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jackson, William C, Johnson, Skyler B, Li, Darren, Foster, Corey, Foster, Benjamin, Song, Yeohan, Schipper, Matthew, Shilkrut, Mark, Sandler, Howard M, Morgan, Todd M, Palapattu, Ganesh S, Hamstra, Daniel A, Feng, Felix Y
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3718717/
https://ncbi.nlm.nih.gov/pubmed/23835115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-8-170
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados